Members of the public face particular challenges when undergoing reproductive genetic screening. Lack of family history with genetic disease has been identified as a key barrier affecting screening uptake and responses to genetic risk. This study explores this obstacle using beta thalassaemia as a case study. Fifteen in‐depth qualitative interviews were conducted exploring the reproductive views and decisions of people at risk of transmitting thalassaemia. Eleven participants had thalassaemia themselves and/or were members of an affected family. Four participants were identified as thalassaemia carriers through genetic screening programmes with no family history. Notable differences were observed between these two groups. For thalassaemic i...
Policy makers have suggested that information about genetic risk factors, which are associated with ...
Background: Genomic medicine is rapidly evolving, particularly in the domain of reproduction. Popula...
Objective: To explore attitudes of clinical and molecular geneticists about the implementation of mu...
Members of the public face particular challenges when undergoing reproductive genetic screening. Lac...
Members of the public face particular challenges when undergoing reproductive genetic screening. Lac...
As population‐level carrier screening panels for reprogenetic information emerge globally, condition...
Background Genomic sequencing technologies have made the possibility of population screening for ...
BACKGROUND: UK and US policy initiatives have suggested that, in the future, patients and clinicians...
Background Genomic sequencing technologies have made the possibility of population screening for ...
Background UK and US policy initiatives have suggested that, in the future, patients and clinicia...
Policy makers have suggested that information about genetic risk factors, which are associated with ...
Purpose: Autosomal recessive conditions, whilst individually rare, are a significant health burden w...
Recent advances in genetics and laboratory techniques have raised difficult issues for both the medi...
From April 2004, the policy for neonatal screening for sickle cell in England has been to base the s...
Over the past fifty years there has been an increase in the number of people in the UK who have a Si...
Policy makers have suggested that information about genetic risk factors, which are associated with ...
Background: Genomic medicine is rapidly evolving, particularly in the domain of reproduction. Popula...
Objective: To explore attitudes of clinical and molecular geneticists about the implementation of mu...
Members of the public face particular challenges when undergoing reproductive genetic screening. Lac...
Members of the public face particular challenges when undergoing reproductive genetic screening. Lac...
As population‐level carrier screening panels for reprogenetic information emerge globally, condition...
Background Genomic sequencing technologies have made the possibility of population screening for ...
BACKGROUND: UK and US policy initiatives have suggested that, in the future, patients and clinicians...
Background Genomic sequencing technologies have made the possibility of population screening for ...
Background UK and US policy initiatives have suggested that, in the future, patients and clinicia...
Policy makers have suggested that information about genetic risk factors, which are associated with ...
Purpose: Autosomal recessive conditions, whilst individually rare, are a significant health burden w...
Recent advances in genetics and laboratory techniques have raised difficult issues for both the medi...
From April 2004, the policy for neonatal screening for sickle cell in England has been to base the s...
Over the past fifty years there has been an increase in the number of people in the UK who have a Si...
Policy makers have suggested that information about genetic risk factors, which are associated with ...
Background: Genomic medicine is rapidly evolving, particularly in the domain of reproduction. Popula...
Objective: To explore attitudes of clinical and molecular geneticists about the implementation of mu...